https://cvshealth.com/news-and-insights/press-releases/cvs-health-names-dr-joneigh-s-khaldun-as-vice-president-and-chief
Monday, October 18, 2021
WOONSOCKET, R.I. — CVS Health (NYSE: CVS) today announced that Joneigh Khaldun, M.D., MPH, FACEP has joined the company as Vice President and Chief Health Equity Officer. She will report to Kyu Rhee, M.D., MPP, Senior Vice President and Aetna Chief Medical Officer.
Dr. Khaldun will lead the strategy to advance health equity for patients, members, providers, customers, and communities served across all lines of the CVS Health business. She and her team will focus on culturally competent care delivery, ensuring it is fully integrated into the design and development of clinical and population health programs, products, services, interactions and communications. She will also work collaboratively with the broader health care system to advance health equity and better support underserved communities.
“As a health care innovation company committed to health equity and breaking down barriers that perpetuate health care disparities, Dr. Khaldun joins our team as Chief Health Equity Officer at a critically important time,” said Rhee. “Her expertise in creating solutions to help improve health outcomes will help us continue addressing health inequities for the customers and communities we serve.”
Prior to joining CVS Health, Dr. Khaldun served as the Chief Medical Executive for the State of Michigan and Chief Deputy Director for Health in the Michigan Department of Health and Human Services, where she was responsible for public health and aging programs, Medicaid and behavioral health. She led Michigan’s COVID-19 response and is credited for Michigan’s early identification of and strategy to address disparities in COVID-19 outcomes. In 2021, she was named by President Biden to the COVID-19 Health Equity Task Force.
Previously, Dr. Khaldun held several positions that leveraged her expertise in improving, expanding and modernizing the delivery of community health services, including Director and Health Officer for the Detroit Health Department and Chief Medical Officer of the Baltimore City Health Department. She was also Director of the Center for Injury Prevention and Control at George Washington University, Founder and Director of the Fellowship in Health Policy in the University of Maryland Department of Emergency Medicine, and Fellow in the Obama-Biden administration’s Office of Health Reform in the U.S. Department of Health and Human Services.
Dr. Khaldun obtained her undergraduate degree from the University of Michigan, medical degree from the University of Pennsylvania, MPH in Health Policy from George Washington University, and completed residency in emergency medicine at SUNY Downstate Medical Center/Kings County Hospital in Brooklyn, NY. She practices emergency medicine part-time at Henry Ford Hospital in Detroit.
She currently serves on the National Advisory Board for the Institute for Healthcare Policy and Innovation at the University of Michigan, the Board of Directors of Big Brothers Big Sisters of Metropolitan Detroit, and on the Health and Medicine Committee of the National Academies of Science, Engineering and Medicine. She is an Adjunct Professor in the Department of Health Policy and Management in the University of Michigan School of Public Health.
About CVS Health
CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and our nearly 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that’s managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Learn more at www.cvshealth.com.
Media contact
Ethan Slavin
860-273-6095
slavine@cvshealth.com
Recent CVS News
- September 10, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against CVS • PR Newswire (US) • 07/29/2024 09:45:00 AM
- CVS Caremark® defines future of pharmacy benefit management • PR Newswire (US) • 07/23/2024 02:05:00 PM
- The Gross Law Firm Reminds CVS Health Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 10, 2024 - CVS • PR Newswire (US) • 07/17/2024 09:45:00 AM
- Microsoft and Apple Exit OpenAI Board, TSMC Exceeds Forecasts with Record Revenue, and Other Key Updates • IH Market News • 07/10/2024 10:42:17 AM
- CVS Health announces quarterly dividend • PR Newswire (US) • 07/08/2024 01:15:00 PM
- CVS Health to hold second quarter 2024 earnings conference call • PR Newswire (US) • 07/08/2024 01:00:00 PM
- FDA Panel Supports Eli Lilly’s Donanemab, Rio Tinto Expands Stake in Boyne Smelters, and More News • IH Market News • 06/11/2024 11:11:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:30:57 PM
- CVS Health to present at the Bernstein 40th Annual Strategic Decisions Conference • PR Newswire (US) • 05/20/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:42:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:41:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:40:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:39:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:38:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:37:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:37:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:36:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:35:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:33:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:32:33 PM
- CVS Pharmacy® introduces Well Market™, a crave-worthy consumables brand • PR Newswire (US) • 05/16/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:19:18 PM
- CVS Health survey shows mental health concerns continue to rise • PR Newswire (US) • 05/09/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:40:04 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 05/08/2024 08:34:36 PM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM